ASTRAZENECA PLC DL-,25/ GB0009895292 /
2024-06-06 4:00:15 PM | Chg. +1.25 | Volume | Bid2024-06-06 | Ask2024-06-06 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
148.40EUR | +0.85% | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 228.91 bill.EUR | - | - |
GlobeNewswire
06-06
Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Laso...
GlobeNewswire
05-08
Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire
05-06
Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GlobeNewswire
05-02
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire
03-28
HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...